AJANTPHARM Ajanta Pharmaceuticals Ltd. — Smart-Money Activity, F&O Buildup & Bulk Deals
Sector: HealthcareAJANTPHARM Chart daily candles · add any indicator · computed in your browser
Loading chart…
Daily bars from exchange end-of-day data; during market hours today’s bar updates with the latest price. Splits and bonuses are adjusted; demergers show as the real gaps they were. Volume profile is estimated from each day’s range. D marks a bulk or block deal day (green: net buying, red: net selling, purple: matched cross). Charting by TradingView Lightweight Charts.
AJANTPHARM Seasonality month by month since 2002 · adjusted month-end closes
AJANTPHARM in October: closed the month higher in 10 of 24 years (2002–2025), with a median move of -1.6% and an average of -1.7%.
Years the month closed higher / years with data, and the median monthly move. Past patterns, not a forecast: most months are close to a coin toss.
Live setups screens AJANTPHARM is on right now — tap to see every stock matching
Smart Money Verdict synthesis of derivatives, deals, and promoter files
Analysis what the data is telling us about AJANTPHARM
Ajanta Pharmaceuticals Ltd. did not have meaningful F&O activity in the last completed session. That doesn't mean the stock is irrelevant — it just means the smart-money signals here come from cash markets and corporate disclosures, covered below.
On the institutional side, MFs are building positions in Ajanta Pharmaceuticals Ltd. — the most recent notable was KOTAK MAHINDRA MUTUAL FUND on the buy side at ₹624 Cr.
Putting it together, the smart-money picture for Ajanta Pharmaceuticals Ltd. lacks a clear directional bias.
F&O Positioning EOD derivatives setup
Quote Details key metrics & weights
Technical Snapshot as of 2026-10-19 close · from 400 sessions of price history
Key Fundamentals headline ratios · Healthcare
Fundamental ratios sourced from public market data, refreshed periodically; verify against company filings before relying on them.
Institutional Deals last 30 sessions (bulk & block)
| Date | Side | Price | Value (Cr) | Counterparty |
|---|---|---|---|---|
| 2026-06-09 | SELL | ₹ 2,968.00 | 1,023.96 | RAVI AGRAWAL TRUST |
| 2026-06-09 | SELL | ₹ 2,968.00 | 1,023.96 | RAVI AGRAWAL TRUST |
| 2026-06-09 | BUY | ₹ 2,968.00 | 623.96 | KOTAK MAHINDRA MUTUAL FUND MF |
| 2026-06-09 | BUY | ₹ 2,968.00 | 623.96 | KOTAK MAHINDRA MUTUAL FUND MF |
| 2026-06-09 | BUY | ₹ 2,968.00 | 400.00 | ADITYA BIRLA SUN LIFE MUTUAL FUND MF |
Insider & Promoter Filings last 60 days
Latest News recent coverage from Reuters, Simply Wall St, MT Newswires and others
AJANTPHARM — frequently asked questions
What is the Ajanta Pharmaceuticals Ltd. share price today?
AJANTPHARM is trading at ₹3,298.90 (+0.00% vs previous close), per the latest update on this page.
What is the P/E ratio of Ajanta Pharmaceuticals Ltd.?
AJANTPHARM (Ajanta Pharmaceuticals Ltd.) has a trailing twelve-month P/E ratio of 36.3.
What is the market cap of Ajanta Pharmaceuticals Ltd.?
AJANTPHARM has a market capitalisation of approximately ₹41,223 crore.
Is AJANTPHARM near its 52-week high?
AJANTPHARM is trading -13.1% from its 52-week high of ₹3,796.00 as of 2026-10-19.
What is the RSI of AJANTPHARM?
The 14-day RSI of AJANTPHARM is 35.4, which is considered neutral.
Is AJANTPHARM above its 200-day moving average?
AJANTPHARM is trading above its 200-DMA of ₹3,151.29 (+4.7% away).
Are FIIs or big investors buying AJANTPHARM?
Strota tracks every bulk and block deal in AJANTPHARM with named buyers and sellers, plus promoter and insider filings — the tables on this page list the most recent institutional activity as disclosed to the exchanges.